Impact of COVID‐19 Restrictions on Estimating Causal Effects: Fluoroquinolones and Tendon Rupture
Angel Y. S. Wong,
Jeremy P. Brown,
John Tazare,
Marleen Bokern,
Elizabeth Williamson,
Jonathan Bartlett,
Charlotte Warren‐Gash,
Ian Douglas Pharmacoepidemiology and Drug Safety
· Wiley
· 2026-10-16
· DOI: 10.1002/pds.70504
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Angel Y. S. Wong, Jeremy P. Brown, John Tazare, Marleen Bokern, Elizabeth Williamson, Jonathan Bartlett et al. Impact of COVID‐19 Restrictions on Estimating Causal Effects: Fluoroquinolones and Tendon Rupture. // Pharmacoepidemiology and Drug Safety. – 2026. – DOI: 10.1002/pds.70504. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pds.70504?af=R
Angel Y. S. Wong, Jeremy P. Brown, John Tazare, Marleen Bokern, Elizabeth Williamson, Jonathan Bartlett, Charlotte Warren‐Gash, & Ian Douglas (2026). Impact of COVID‐19 Restrictions on Estimating Causal Effects: Fluoroquinolones and Tendon Rupture. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70504
Angel Y. S. Wong, et al. “Impact of COVID‐19 Restrictions on Estimating Causal Effects: Fluoroquinolones and Tendon Rupture.” Pharmacoepidemiology and Drug Safety, 2026. doi:10.1002/pds.70504.
@article{Wong2026,
title = {Impact of COVID‐19 Restrictions on Estimating Causal Effects: Fluoroquinolones and Tendon Rupture},
author = {Wong, Angel Y. S. and Brown, Jeremy P. and Tazare, John and Bokern, Marleen and Williamson, Elizabeth and Bartlett, Jonathan and Warren‐Gash, Charlotte and Douglas, Ian},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
doi = {10.1002/pds.70504},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pds.70504?af=R}
}